mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.00082 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.9 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.3 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |